Relationship between pepsinogen I&II and H. pylori Infection considered with grade of atrophy and gastroduodenal diseases

Digestive Diseases and Sciences

Volumn 48, Issue 9, 2003, Pages 1839-1845

  Karita, Mikio ^d   Noriyasu, Ayumi ^a   Kosako, Eiko ^a   Teramukai, Satoshi ^b   Matsumoto, Satoru ^c  

^a Yamaguchi shi Yamaguchi Japan   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

^d Hofu Onsen Hospital   (Japan)

Author keywords

Atrophic pattern; H. pylori; Pepsinogen I II; Peptic ulcer

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM ANTIBODY; PEPSINOGEN I; PEPSINOGEN II;

ANTIBIOTIC THERAPY; ARTICLE; ATROPHIC GASTRITIS; BIOPSY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DUODENOSCOPY; DYSPEPSIA; ENZYME INDUCTION; GASTROINTESTINAL DISEASE; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UPREGULATION;

ATROPHY; DUODENAL DISEASES; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; PEPSINOGEN A; PEPSINOGEN C; PROSPECTIVE STUDIES; UP-REGULATION;

EID: 0141650625     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025423902479     Document Type: Article

References (17)

1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311-1315, 1984
2. Blaser MJ: Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161:626-633, 1990
3. Kouchiyama T, Tada M, Shigeeda M, Karita M, Yanai H, Kawano H, Murakami A, Okazaki Y, Takemoto T, Konishi H, Nakazawa T: Significance of Campylobacter pylori in chronic castritis. In Campylobacter pylori and Gastroduodenal Diseases, (Vol. 1). T Takemoto, K Kawai, T Shimoyama (eds). Tokyo, Organizing Committee of Tokyo International Symposium on Campylobacter pylori, 1989, pp 184-194
4. Kimura K: Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 63:584-592, 1972
5. Varis K, Isokoski M: Screening of type A gastritis. Ann Clin Res 13:133-138, 1981
6. Correa P: Chronic gastritis. In Gastrointestinal and Oesophageal Pathology. R Whitehead (ed). Edinburgh, Churchhill Livingstone, 1989, pp 405-406
7. Samloff IM: Cellular localization og group I pepsinogens in human gastric mucosa by immunofluorenscence. Gastroeterology 65:185-188, 1971
8. Oderda G, Vaira D, Holton J, Dowsett JF, Ansaldi N: Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut 30:912-916, 1989
9. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham D: Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102:760-766, 1992
10. Samloff IM, Liebman WM: Cellular localization of group II pepsinogens in human stomach and duodenum by immunofluorenscence. Gastroeterology 65:36-42, 1973.
11. Oderda G, Vaira D, Holton J, Ainley C, Altare F, Ansaldi N: Amoxicillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1:690-692, 1989
12. Karita M., Matsumoto S: Why did the infiltration of the lymphocyte occur in Helicobacter pylori negative case by culture? Jpn J Gastroenterol 96:450, 1999 (in Japanese)
13. Karita M, Tummuru MKR, Wirth HP, and Blaser MJ: Effect of growth phase and acid shock on Helicobacter pylori cagA expression. Infect Immun 64;4501-4507, 1996
14. Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ: Clinical and pathological importance of heterogeneity in vacA, the vacuolationg cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92-99, 1997
15. Huang SC, Miki K, Furihata C: Enzyme-linked immunosorbent assay of serum pepsinogen I and II using monoclonal antibodies - with data on peptic ulcer and gastric cancer. Clin Chim Acta 175:37-50, 1988
16. Karita M, Matsumoto S: Subgrouping of Helicobacter pylori strains into Japanese and USA type by PCR based on each cagA. In The 3rd Annual Meeting of the Japanese Research Society for Helicobacter pylori Related Gastrocluodenal Diseases. T Takemoto, K Kimura, T Shimoyama, T Fujioka (eds). Tokyo, The Japanese Research Society for Helicobacter pylori-Related Gastroduodenal Diseases, 1997, p 76
17. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HPM, Meuwissen SGM: Long-term sequelae of Helicobacter pylori gastritis. Lancet 345:1525-1528, 1995